Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of delta‑like protein 3 combined with thyroid transcription factor‑1 in small‑cell lung cancer

27 Jun 2019

Abstract excerpt

Rovalpituzumab tesirine is a promising delta-like protein 3 (DLL3)-targeted antibody-drug conjugate for the treatment of small-cell lung cancer (SCLC). Thyroid transcription factor-1 (TTF-1) and DLL3 protein are associated with SCLC, and may be used to identify patients, who respond to the DLL3-targeted therapy. However, little is known about the expression pattern of the DLL3 protein, and the prognostic value of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31452726
DOI: 10.3892/ol.2019.10538

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of delta‑like protein 3 combined with thyroid transcription factor‑1 in small‑cell lung cancerPMID 31452726Read ↗

LAG-3 and PD-1/PD-L1 Inhibitors Might Become a Promising Treatment for Small Cell Lung CancerSemantic proximity Read ↗

LAG-3 and PD-1/PD-L1 inhibitors might become a promising treatment for small cell lung cancerSemantic proximity Read ↗

DLL3 Expression in a Genotyped Cohort of Sporadic Medullary Thyroid Carcinomas.Semantic proximity Read ↗

Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview.Semantic proximity Read ↗

Multidimensional Analysis of B7 Homolog 3 RNA Expression in Small Cell Lung Cancer Molecular Subtypes.Semantic proximity Read ↗

Molecular subtypes, predictive markers and prognosis in small-cell lung carcinomaSemantic proximity Read ↗

Delta-Like Protein 3 Expression and Targeting in Merkel Cell CarcinomaSemantic proximity Read ↗

LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.Semantic proximity Read ↗

DLL3 regulates Notch signaling in small cell lung cancerSemantic proximity Read ↗

POU2F3-Expressing Small Cell Lung Carcinoma and Large Cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic OverlapSemantic proximity Read ↗

Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung CarcinomaSemantic proximity Read ↗

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.